Literature DB >> 21148085

Structural determinants of vascular endothelial growth factor-D receptor binding and specificity.

Veli-Matti Leppänen1, Michael Jeltsch, Andrey Anisimov, Denis Tvorogov, Kukka Aho, Nisse Kalkkinen, Pyry Toivanen, Seppo Ylä-Herttuala, Kurt Ballmer-Hofer, Kari Alitalo.   

Abstract

Vascular endothelial growth factors (VEGFs) and their tyrosine kinase receptors (VEGFR-1-3) are central mediators of angiogenesis and lymphangiogenesis. VEGFR-3 ligands VEGF-C and VEGF-D are produced as precursor proteins with long N- and C-terminal propeptides and show enhanced VEGFR-2 and VEGFR-3 binding on proteolytic removal of the propeptides. Two different proteolytic cleavage sites have been reported in the VEGF-D N-terminus. We report here the crystal structure of the human VEGF-D Cys117Ala mutant at 2.9 Å resolution. Comparison of the VEGF-D and VEGF-C structures shows similar extended N-terminal helices, conserved overall folds, and VEGFR-2 interacting residues. Consistent with this, the affinity and the thermodynamic parameters for VEGFR-2 binding are very similar. In comparison with VEGF-C structures, however, the VEGF-D N-terminal helix was extended by 2 more turns because of a better resolution. Both receptor binding and functional assays of N-terminally truncated VEGF-D polypeptides indicated that the residues between the reported proteolytic cleavage sites are important for VEGF-D binding and activation of VEGFR-3, but not of VEGFR-2. Thus, we define here a VEGFR-2-specific form of VEGF-D that is angiogenic but not lymphangiogenic. These results provide important new insights into VEGF-D structure and function.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21148085     DOI: 10.1182/blood-2010-08-301549

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  31 in total

Review 1.  The lymphatic vasculature in disease.

Authors:  Kari Alitalo
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

2.  Understanding and targeting resistance to anti-angiogenic therapies.

Authors:  Jeffrey M Clarke; Herbert I Hurwitz
Journal:  J Gastrointest Oncol       Date:  2013-09

Review 3.  Receptor tyrosine kinase-mediated angiogenesis.

Authors:  Michael Jeltsch; Veli-Matti Leppänen; Pipsa Saharinen; Kari Alitalo
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-09-01       Impact factor: 10.005

Review 4.  Plexin structures are coming: opportunities for multilevel investigations of semaphorin guidance receptors, their cell signaling mechanisms, and functions.

Authors:  Prasanta K Hota; Matthias Buck
Journal:  Cell Mol Life Sci       Date:  2012-06-29       Impact factor: 9.261

Review 5.  Targeting allosteric disulphide bonds in cancer.

Authors:  Philip J Hogg
Journal:  Nat Rev Cancer       Date:  2013-05-10       Impact factor: 60.716

Review 6.  Targeted inhibition of VEGF receptor 2: an update on ramucirumab.

Authors:  Jeffrey Melson Clarke; Herbert I Hurwitz
Journal:  Expert Opin Biol Ther       Date:  2013-06-26       Impact factor: 4.388

Review 7.  Control of blood proteins by functional disulfide bonds.

Authors:  Diego Butera; Kristina M Cook; Joyce Chiu; Jason W H Wong; Philip J Hogg
Journal:  Blood       Date:  2014-02-12       Impact factor: 22.113

8.  Cooperative interactions between VEGFR2 extracellular Ig-like subdomains ensure VEGFR2 dimerization.

Authors:  Christopher King; Daniel Wirth; Samuel Workman; Kalina Hristova
Journal:  Biochim Biophys Acta Gen Subj       Date:  2017-08-25       Impact factor: 3.770

9.  Characterization of a reduced form of plasma plasminogen as the precursor for angiostatin formation.

Authors:  Diego Butera; Troels Wind; Angelina J Lay; Julia Beck; Francis J Castellino; Philip J Hogg
Journal:  J Biol Chem       Date:  2013-12-12       Impact factor: 5.157

10.  Motif mimetic of epsin perturbs tumor growth and metastasis.

Authors:  Yunzhou Dong; Hao Wu; H N Ashiqur Rahman; Yanjun Liu; Satish Pasula; Kandice L Tessneer; Xiaofeng Cai; Xiaolei Liu; Baojun Chang; John McManus; Scott Hahn; Jiali Dong; Megan L Brophy; Lili Yu; Kai Song; Robert Silasi-Mansat; Debra Saunders; Charity Njoku; Hoogeun Song; Padmaja Mehta-D'Souza; Rheal Towner; Florea Lupu; Rodger P McEver; Lijun Xia; Derek Boerboom; R Sathish Srinivasan; Hong Chen
Journal:  J Clin Invest       Date:  2015-11-16       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.